🩸 HematologyInjection (SC)
Givlaari
Givosiran
RNA interference therapy for acute hepatic porphyria that reduces ALAS1 mRNA in the liver.
Form
Injection (SC)
Uses
1
Side effects
5
Category
Hematology
01
What is Givlaari used for?
- Acute hepatic porphyria (AHP)
02
Givosiran side effects
The following side effects have been reported for Givosiran. Their order does not indicate how often an effect occurs.
Nausea
Fatigue
Injection site reactions
Elevated liver enzymes
Renal toxicity
03
Givosiran warnings & precautions
- Monitor liver function and renal function
- Dose adjustments needed in hepatic impairment
Loading FDA data…
04
Frequently asked questions
05
Related medications
Share
Share this drug info.
Help friends and family understand Givlaari in plain language.
Disclaimer: This information is sourced from the FDA openFDA database and is provided for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before starting or changing medication.